Aldara for the Treatment of Extensive Alopecia Areata
Status:
Completed
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
We propose to examine the efficacy and tolerability of Aldara Cream 5% for the treatment of
extensive alopecia areata. Aldara is a immune-response modifier. The drug induces the
production of cytokines which are small, hormone-like proteins involved in cellular
communication during immune responses. We hypothesize that this drug will effect the
inflammatory cells present around hair follicles in patients with alopecia areata.